A. Solida

Discipline

Psychologie (10) Education (1)

Type de document

Articles (18) Recensions (2) Autres (1)

Co-auteur

Date

Source

Mot-clé

Patients (16) Patients (15) Treatment (14) Human beings (13) Psychoses (10) Months (8) risque (7) adulte (7) Risk (7) adulte (7) Older people (6) temps (durée) (5) âge (5) Diagnosis (5) Weight gain (5) Programs (5) Time (5) Symptoms (5) Diagnosis (5) Age (5) Age (5) cohorte (5) maladie (5) puits (4) poids (4) effet (4) ordre (4) Order (4) Evaluation (4) Weight (4)

Documents écrit par A. Solida (18) | parle de A. Solida (0)

Improving Pathways to Care for Patients at High Psychosis Risk in Switzerland: PsyYoung Study Protocol.
C. Conchon et al. (12 juil. 2023)
The differential impact of duration of untreated psychosis on functioning and quality of life: A threshold analysis.
P. Golay et al.
Dynamics between insight and medication adherence in first-episode psychosis: Study of 3-year trajectories.
J. Elowe et al. (15 août 2022)
Symptom dimensions stability over time in recent onset psychosis: A prospective study.
P. Golay et al.
Daily Dose Effects of Risperidone on Weight and Other Metabolic Parameters: A Prospective Cohort Study.
M. Piras et al. (9 mai 2022)
Six months functional response to early psychosis intervention program best predicts outcome after three years.
P. Golay et al.
Effect of Quetiapine, from Low to High Dose, on Weight and Metabolic Traits: Results from a Prospective Cohort Study.
C. Dubath et al.
Correction: Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort.
C. Dubath et al. (7 oct. 2021)
PsyYoung : un projet pluri-cantonal pour faciliter l’accès aux soins des jeunes à risque de développer une psychose [PsyYoung: A transcantonal project for facilitating access to care for young people at risk for psychotic disorders]
C. Andreou et al. (22 sept. 2021)
Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort.
C. Dubath et al. (26 juin 2021)
Rate and predictors of disengagement in an early psychosis program with time limited intensification of treatment.
P. Golay et al.
Evaluation of Cardiometabolic Risk in a Large Psychiatric Cohort and Comparison With a Population-Based Sample in Switzerland.
C. Dubath et al. (31 mars 2020)
Psychological trauma occurring during adolescence is associated with an increased risk of greater waist circumference in Early Psychosis patients treated with psychotropic medication.
L. Alameda et al. (2020)
Migration in patients with early psychosis: A 3-year prospective follow-up study.
P. Golay et al.
Age at the time of onset of psychosis: A marker of specific needs rather than a determinant of outcome?
P. Golay et al.
Formulation de cas dans la psychose débutante : Quels outils pour le travail en équipe? [Case Formulation in Early Psychosis: What are the Tools for Teamwork?]
P. S. Baumann et al.
Suivi du syndrome métabolique induit par les antipsychotiques atypiques: recommandations et perspectives pharmacogénétiques [Follow-up of the metabolic syndrome induced by atypical antipsychotics: recommendations and pharmacogenetics perspectives]
E. Choong et al. (17 sept. 2008)
Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5.
C. Wider et al. (2008)